Biocon

In News

Biocon Biologics Adds Keytruda, Herceptin, Opdivo Biosimilars To Its Portfolio - Citeline News & Insights

Citeline News & Insights - Jan 09, 2026

Biocon Biologics to Expand Biosimilar Oncology Portfolio, Outline Strategic Vision at the 2026 J.P. Morgan Healthcare Conference - Yahoo Finance

Yahoo Finance - Jan 06, 2026

Biocon Sets Record Date for Rs 200 Crore Listed Commercial Paper Maturity - TipRanks

TipRanks - Jan 08, 2026

Biocon to introduce Keytruda among three new oncology biosimilars at JPM 2026 - ETPharma.com

ETPharma.com - Jan 07, 2026

Biocon buys out Viatris and others from biosimilar subsidiary - Fierce Pharma

Fierce Pharma - Dec 09, 2025

Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited - PR Newswire

PR Newswire - Dec 06, 2025

Viatris signs agreements with Biocon on $815m stake sale - Pharmaceutical Technology

Pharmaceutical Technology - Dec 08, 2025

Biocon Limited to integrate Biocon Biologics - The Pharma Letter

The Pharma Letter - Dec 09, 2025

Biocon Biologics Eyes USD 75 Billion Oncology Market, Adds 3 New Biosimilar Drugs - Medical Dialogues

Medical Dialogues - Jan 07, 2026

US proposal to halve biosimilar development costs for India's Biocon, top exec says - Reuters

Reuters - Nov 13, 2025

Biocon opens first US manufacturing facility in New Jersey - NJBIZ

NJBIZ - Sep 22, 2025

Indian Tycoon Kiran Mazumdar-Shaw’s Biocon Buyout Deal Values Biologics Unit At $5.5 Billion - Forbes

Forbes - Dec 08, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment